A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma
Clinical trial NCT02326025 · COMPLETED
Trial details
- NCT number
- NCT02326025
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-22
- Primary completion
- 2015-05-20
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.